MOTS-c

What is MOTS-c?

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a peptide encoded within the mitochondrial genome — making it one of a small class of mitochondrial-derived peptides (MDPs) that have only recently been identified and characterized. It was first described in 2015 by researchers at the University of Southern California and has since emerged as one of the most exciting peptides in longevity and metabolic medicine.

Unlike most peptides, which are encoded in the nuclear genome, MOTS-c is produced by the mitochondria themselves — the organelles responsible for cellular energy production. It acts as a retrograde signal from the mitochondria to the nucleus, regulating gene expression in response to metabolic stress. Its primary effects include improved insulin sensitivity, enhanced glucose uptake in skeletal muscle, activation of AMPK (a key metabolic regulator), and support for mitochondrial biogenesis.

MOTS-c levels decline with age and are lower in individuals with obesity, type 2 diabetes, and metabolic syndrome — conditions characterized by mitochondrial dysfunction and insulin resistance. Restoring MOTS-c levels through supplementation has shown remarkable effects in preclinical models, including reversal of diet-induced obesity, improved insulin sensitivity, and extended lifespan.

Metabolic regulation from the mitochondrial genome

AMPK Activation

MOTS-c activates AMP-activated protein kinase (AMPK) — the master metabolic regulator that promotes glucose uptake, fatty acid oxidation, mitochondrial biogenesis, and autophagy. AMPK activation mimics many of the metabolic benefits of exercise and caloric restriction.

Insulin Sensitivity Enhancement

MOTS-c improves insulin signaling in skeletal muscle and adipose tissue — increasing glucose uptake and reducing insulin resistance. This effect is independent of weight loss and occurs at the cellular level.

Mitochondrial Biogenesis

MOTS-c promotes the formation of new mitochondria — increasing cellular energy capacity and improving the efficiency of ATP production. More mitochondria means more energy, better endurance, and faster recovery.

Folate Cycle Regulation

MOTS-c regulates the folate cycle and one-carbon metabolism — pathways critical for DNA synthesis, methylation, and cellular repair. This connects MOTS-c to epigenetic regulation and cellular longevity.

Exercise Mimetic Effects

MOTS-c produces many of the metabolic adaptations associated with exercise — including improved glucose metabolism, increased fat oxidation, and enhanced mitochondrial function — making it particularly valuable for individuals with limited exercise capacity.

What patients report

—

Improved insulin sensitivity and glucose metabolism

—

Enhanced mitochondrial function and cellular energy production

—

Support for healthy body weight and fat metabolism

—

Improved exercise capacity and endurance

—

Faster recovery from physical exertion

—

Support for metabolic syndrome and pre-diabetes management

—

Cellular longevity through AMPK and autophagy activation

—

Potential neuroprotective and anti-aging effects

—

Complementary to exercise — amplifies metabolic adaptations

Who may benefit from MOTS-c?

—

Individuals with insulin resistance, pre-diabetes, or metabolic syndrome

—

Those seeking to improve body composition and metabolic health

—

Athletes and active individuals seeking enhanced exercise capacity and recovery

—

Health-conscious adults seeking cellular longevity and mitochondrial optimization

—

Individuals with age-related metabolic decline

—

Those combining MOTS-c with Tesamorelin for comprehensive metabolic support

—

Patients in our Longevity & Performance or Advanced Peptide programs

Frequently asked questions

How is MOTS-c different from other metabolic peptides?

MOTS-c is unique because it is encoded in the mitochondrial genome — not the nuclear genome like most peptides. This makes it a direct signal from the mitochondria, the cell's energy-producing organelles. Its effects on AMPK activation and insulin sensitivity are distinct from GH-stimulating peptides like Tesamorelin and represent a complementary metabolic pathway.

Can MOTS-c help with type 2 diabetes?

MOTS-c has demonstrated significant improvements in insulin sensitivity and glucose metabolism in preclinical models and early human research. While it is not a replacement for diabetes medications, it may be a valuable adjunct for individuals with insulin resistance or pre-diabetes. Your clinician will assess whether MOTS-c is appropriate for your metabolic health profile.

Does MOTS-c work without exercise?

Yes — MOTS-c produces metabolic improvements even without exercise, through its direct effects on AMPK activation and insulin signaling. However, the combination of MOTS-c with regular exercise produces synergistic benefits that exceed either intervention alone. MOTS-c is particularly valuable for individuals who cannot exercise at high intensity due to injury, illness, or other limitations.

Can I combine MOTS-c with Tesamorelin?

Yes — MOTS-c and Tesamorelin address metabolic health through complementary mechanisms. Tesamorelin reduces visceral fat through GH-mediated lipolysis, while MOTS-c improves insulin sensitivity and mitochondrial function. Together they create a comprehensive metabolic optimization protocol. Your clinician will design the appropriate combination and dosing schedule.

Is MOTS-c research still emerging?

Yes — MOTS-c was only identified in 2015 and is one of the newer peptides in clinical use. The preclinical evidence is compelling, and early human data is promising. As with all emerging therapies, your clinician will discuss the current state of evidence and help you make an informed decision about whether MOTS-c is appropriate for your goals.

Our services